EP2575802
Fosfaplatín og notkun þeirra til að meðhöndla krabbamein
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
2.6.2011EP published:
16.11.2016EP application number:
11726567.8
EP translation filed:
8.12.2016Grant published:
15.1.2017EPO information:
European Patent Register
Max expiry date:
1.6.2031Expiry date:
1.6.2026Next due date:
30.6.2026
Title:
PHOSPHAPLATINS AND THEIR USE FOR TREATMENT OF CANCERS
Timeline
Today
2.6.2011EP application
16.11.2016EP Publication
8.12.2016Translation submitted
15.1.2017Registration published
1.6.2026Expires
Owner
Name:
Ohio UniversityAddress:
340 West State Street Unit 14, 45701, Athens, OH, US
Inventor
Name:
BOSE, Rathindra, N.Address:
Athens, OH, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
351514 PDate:
4.6.2010Country:
US
Classification
Categories:
A61K 31/282, A61K 33/24, A61P 35/00, C07F 15/00
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 17.5.2017
Expires: 1.6.2018
Payer: Sigurjónsson & Thor ehf.
Number: 8
Paid: 18.5.2018
Expires: 1.6.2019
Payer: Sigurjónsson & Thor ehf.
Number: 9
Paid: 20.5.2019
Expires: 1.6.2020
Payer: Sigurjónsson & Thor ehf.
Number: 10
Paid: 19.5.2020
Expires: 1.6.2021
Payer: Sigurjónsson & Thor ehf.
Number: 11
Paid: 18.5.2021
Expires: 1.6.2022
Payer: Sigurjónsson & Thor ehf.
Number: 12
Paid: 18.5.2022
Expires: 1.6.2023
Payer: Patice ehf.
Number: 13
Paid: 24.5.2023
Expires: 1.6.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 21.5.2024
Expires: 1.6.2025
Payer: Árnason Faktor ehf.
Number: 15
Paid: 20.5.2025
Expires: 1.6.2026
Payer: Árnason Faktor ehf.